Zhuhai Trinomab Pharmaceutical Company Description

Zhuhai Trinomab Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, and commercializes therapeutics for infectious diseases and pain-related or autoimmune disorders.

The company’s product includes Siltartoxatug Injection (TNM002), a recombinant anti-tetanus toxin monoclonal antibody that neutralizes the toxic effects that target the human neural system.

The company was founded in 2015 and is based in Zhuhai, China.

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Country	China
Founded	2015
Industry	Biological Products, Except Diagnostic Substances
Employees	843
CEO	Weihong Zheng

Contact Details

Address: Zhizao Street Zhuhai, 519090 China
Phone	86 75 6779 5986
Website	trinomab.com

Stock Details

Ticker Symbol	688806
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	2836

Key Executives

Name	Position
Weihong Zheng	Chief Executive Officer
Xiaoming Chi	Chief Financial Officer